1. Home
  2. RCL vs BSX Comparison

RCL vs BSX Comparison

Compare RCL & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Royal Caribbean Cruises Ltd.

RCL

Royal Caribbean Cruises Ltd.

BUY

Current Price

$288.29

Market Cap

81.6B

ML Signal

BUY

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$42.04

Market Cap

68.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCL
BSX
Founded
1968
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.6B
68.0B
IPO Year
1997
2010

Fundamental Metrics

Financial Performance
Metric
RCL
BSX
Price
$288.29
$42.04
Analyst Decision
Buy
Buy
Analyst Count
29
31
Target Price
★ $350.44
$61.00
AVG Volume (30 Days)
2.9M
★ 17.9M
Earning Date
10-27-2026
10-28-2026
Dividend Yield
★ 2.18%
N/A
EPS Growth
42.69
★ 55.20
EPS
★ 7.68
1.51
Revenue
$8,777,845,000.00
★ $9,076,000,000.00
Revenue This Year
$9.12
$5.59
Revenue Next Year
$7.25
$4.92
P/E Ratio
$35.81
★ $28.15
Revenue Growth
N/A
★ 12.49
52 Week Low
$222.22
$42.20
52 Week High
$356.39
$105.65

Technical Indicators

Market Signals
Indicator
RCL
BSX
Relative Strength Index (RSI) 65.29 34.47
Support Level $278.01 N/A
Resistance Level $297.43 $46.06
Average True Range (ATR) 10.38 0.99
MACD 6.20 -0.07
Stochastic Oscillator 99.59 3.47

Price Performance

Historical Comparison
RCL
BSX

About RCL Royal Caribbean Cruises Ltd.

Royal Caribbean is the world's second-largest cruise company by revenues, operating 71 ships across five global and partner brands in the cruise vacation industry. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises. The selection of brands in the portfolio allows Royal to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in 2021, plans to launch its new Celebrity River Cruise brand in 2027, and is set to operate eight private destination locations by 2028.

About BSX Boston Scientific Corporation

Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: